CSX

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Total revenue 3.42 B3.57 B3.59 B3.51 B3.48 B3.94 B 14.51 B Gross profit 3.15 B3.31 B3.31 B3.24 B3.18 B3.49 B 13.21 B Operating expenses 2.4 B2.31 B2.51 B2.41 B2.24 B2.46 B 9.62 B Selling/general/admin expenses 14 M15 M14 M11 M13 M27 M 65 M Research & development —————— — Operating income 1.04 B1.28 B1.09 B1.11 B1.25 B1.51 B 4.96 B Non-Operating Income, Total 26 M22 M21 M23 M23 M25 M 92 M Interest expense, net of interest capitalized 209 M212 M210 M213 M213 M211 M 847 M Non-Operating Income, excl. Interest Expenses 26 M22 M21 M23 M23 M25 M 92 M Unusual income/expense —————— — Pretax income 858 M1.09 B898 M920 M1.06 B1.32 B 4.2 B Equity in earnings —————— — Taxes 212 M264 M204 M200 M256 M318 M 978 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 646 M829 M694 M720 M807 M1 B 3.22 B Discontinued operations —————— — Net income 646 M829 M694 M720 M807 M1 B 3.22 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 646 M829 M694 M720 M807 M1 B 3.22 B Basic earnings per share (Basic EPS) 0.340.440.370.390.430.54 1.73 Diluted earnings per share (Diluted EPS) 0.340.440.370.390.430.54 1.73 Average basic shares outstanding 1.89 B1.87 B1.86 B1.87 B1.86 B1.85 B — Diluted shares outstanding 1.89 B1.87 B1.87 B1.87 B1.86 B1.86 B — EBITDA 1.18 B1.43 B1.22 B1.23 B1.35 B1.44 B 5.25 B EBIT 752 M999 M792 M829 M938 M1.03 B 3.59 B Cost of revenue 275 M269 M281 M270 M302 M446 M 1.3 B Other cost of goods sold 275 M269 M281 M270 M302 M446 M 1.3 B Depreciation & amortization (cash flow) 425 M427 M424 M404 M415 M411 M 1.65 B